A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
Clinical trial NCT01823835 · TERMINATED
Trial details
- NCT number
- NCT01823835
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-29
- Primary completion
- 2020-03-13
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.